Status:
RECRUITING
Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)
Lead Sponsor:
The Second Affiliated Hospital of Hainan Medical University
Conditions:
Overall Response Rate
Oncology
Eligibility:
All Genders
18-75 years
Brief Summary
Aim to observe the application of MR-Linac for precision radiotherapy of tumours, analyse its therapeutic effect, toxic and side effects,Characteristics of dosimetric parameters etc.
Detailed Description
Primary endpoint: · Overall response rate (ORR) : It refers to the proportion of patients whose tumor volume reduction reaches the pre-specified value and can maintain the minimum time requirement, w...
Eligibility Criteria
Inclusion
- Patients are undergoing or have undergone imaging or treatment at the MR linac;
- Age 18-75 years, male or female;
- ECOG score 0-2, life expectancy \> 6 months;
- Patients provide written informed consent.
Exclusion
- Contraindications to MRI, such as claustrophobia and metallic or electronic implants incompatible with MRI;
- The presence of severe comorbidities that, in the opinion of the investigator, · preclude the toleration or completion of radiotherapy;
- Acute inflammatory disease requiring systemic therapy;
- The presence of active infectious disease;
- Pregnant women, nursing mothers, and patients planning to have children during the study period.
Key Trial Info
Start Date :
August 19 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT06531681
Start Date
August 19 2023
End Date
December 31 2028
Last Update
February 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Affiliated Hospital of Hainan Medical University
Haikou, China, 570311